Connor, Clark & Lunn Investment Management Ltd. Savara Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Savara Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 309,835 shares of SVRA stock, worth $799,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares

309,835

Previous 778,954 60.22%

Holding current value

$799,374

Previous $2.16 Million 67.27%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$1.99 - $3.4 $933,546 - $1.6 Million	-469,119 Reduced 60.22%	309,835 $706,000
Q1 2025 May 12, 2025	SELL	$2.32 - $3.14 $135,750 - $183,730	-58,513 Reduced 6.99%	778,954 $2.16 Million
Q4 2024 Feb 10, 2025	BUY	$2.94 - $4.07 $431,762 - $597,712	146,858 Added 21.26%	837,467 $2.57 Million
Q3 2024 Nov 08, 2024	BUY	$3.96 - $5.07 $959,306 - $1.23 Million	242,249 Added 54.03%	690,609 $2.93 Million
Q2 2024 Aug 09, 2024	BUY	$3.66 - $5.34 $203,631 - $297,101	55,637 Added 14.17%	448,360 $1.81 Million
Q1 2024 May 09, 2024	BUY	$4.19 - $5.59 $520,716 - $694,702	124,276 Added 46.29%	392,723 $1.96 Million
Q4 2023 Feb 09, 2024	BUY	$3.18 - $4.9 $134,253 - $206,868	42,218 Added 18.66%	268,447 $1.26 Million
Q3 2023 Nov 13, 2023	SELL	$2.97 - $3.88 $39,881 - $52,100	-13,428 Reduced 5.6%	226,229 $855,000
Q2 2023 Aug 10, 2023	BUY	$1.69 - $3.24 $54,098 - $103,715	32,011 Added 15.42%	239,657 $764,000
Q1 2023 May 09, 2023	BUY	$1.6 - $2.82 $52,116 - $91,855	32,573 Added 18.61%	207,646 $404,000
Q4 2022 Feb 10, 2023	BUY	$1.11 - $1.64 $3,505 - $5,179	3,158 Added 1.84%	175,073 $271,000
Q3 2022 Nov 10, 2022	BUY	$1.36 - $1.88 $37,376 - $51,668	27,483 Added 19.03%	171,915 $266,000
Q2 2022 Aug 05, 2022	BUY	$1.1 - $1.58 $10,299 - $14,793	9,363 Added 6.93%	144,432 $220,000
Q1 2022 May 12, 2022	SELL	$1.05 - $1.36 $17,146 - $22,208	-16,330 Reduced 10.79%	135,069 $177,000
Q4 2021 Feb 10, 2022	SELL	$1.04 - $1.34 $12,631 - $16,275	-12,146 Reduced 7.43%	151,399 $188,000
Q3 2021 Nov 12, 2021	BUY	$1.18 - $1.64 $23,556 - $32,739	19,963 Added 13.9%	163,545 $226,000
Q2 2021 Aug 12, 2021	BUY	$1.51 - $2.29 $163,010 - $247,214	107,954 Added 303.0%	143,582 $244,000
Q1 2021 May 13, 2021	BUY	$1.17 - $2.33 $41,684 - $83,013	35,628 New	35,628 $74,000

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

167M

Call Options Held

38.7K

Put Options Held

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $294M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Savara Inc Transaction History